TABLE 3.
Multivariate analysis for predictors of indexes of insulin resistance at 12 mo
| Dependent variables and predictors | β | P |
| Model 11 | ||
| lnHOMA index | ||
| BMI at baseline | 0.020 | 0.004 |
| Concentration at baseline | 0.559 | <0.0001 |
| High to low dose | 0.000 | |
| McAuley index | ||
| BMI at baseline | −0.038 | 0.035 |
| Concentration at baseline | 0.647 | <0.0001 |
| High to low dose | −0.090 | |
| Model 22 | ||
| lnHOMA index | ||
| BMI at baseline | 0.043 | <0.0001 |
| Prediabetes at baseline | 0.181 | 0.012 |
| High to low dose | −0.040 | |
| McAuley index | ||
| BMI at baseline | −0.119 | <0.0001 |
| Prediabetes at baseline | −0.089 | |
| High to low dose | 0.031 | |
| Model 33 | ||
| lnHOMA index | ||
| BMI at baseline | 0.020 | 0.004 |
| Concentration at baseline | 0.571 | <0.0001 |
| High to low dose | 0.001 | |
| McAuley index | ||
| BMI at baseline | −0.037 | 0.041 |
| Concentration at baseline | 0.658 | <0.0001 |
| High to low dose | −0.094 | |
| Model 44 | ||
| lnHOMA index | ||
| BMI at baseline | 0.020 | 0.004 |
| Concentration at baseline | 0.559 | <0.0001 |
| McAuley index | ||
| BMI at baseline | −0.038 | 0.036 |
| Concentration at baseline | 0.645 | <0.0001 |
Adjusted for BMI (in kg/m2) index of insulin resistance and vitamin D dose.
Adjusted for BMI, prediabetes, and vitamin D dose.
Adjusted as for model 1 and for age and statin use.
Adjusted as for model 3 but covariates entered stepwise.